Expectant management for men with early stage prostate cancer

@article{Filson2015ExpectantMF,
  title={Expectant management for men with early stage prostate cancer},
  author={Christopher P. Filson and L. Marks and M. Litwin},
  journal={CA: A Cancer Journal for Clinicians},
  year={2015},
  volume={65}
}
Answer questions and earn CME/CNE 
Expectant management of veterans with early‐stage prostate cancer
TLDR
The association between various factors and expectant management use among veterans diagnosed with prostate cancer is evaluated and the underused use of pregnant management has been underused. Expand
Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non‐definitive treatment
TLDR
To investigate the outcomes of patients with upper tract urothelial carcinoma with non‐definitive therapy, which currently remains unknown, using a novel approach called ‘cell reprograming’. Expand
National trends in management of localized prostate cancer: A population based analysis 2004‐2013
TLDR
This work sought to better understand how the changing landscape influenced treatment utilization in the United States as national screening guidelines have been updated and diagnostic practice patterns evolved. Expand
Radical prostatectomy versus deferred treatment for localised prostate cancer.
TLDR
Assessment of effects of RP compared with deferred treatment for clinically localised prostate cancer found that radical prostatectomy versus watchful waiting RP probably reduces the risk of death from any cause and probably reducesThe risk of developing metastatic disease. Expand
Combination Treatment Options for Castration-Resistant Prostate Cancer
TLDR
Combination treatment is a strategy for treating this lethal disease and thus will be the focus of discussion in this chapter. Expand
Long‐Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance
TLDR
A large proportion of men had unfavorable pathology findings at deferred radical prostatectomy and the index tumor was frequently not identified and there is a clear need for better risk classification and protocols to determine disease progression during active surveillance. Expand
A prospective study of the short‐term quality‐of‐life outcomes of patients undergoing transperineal prostate biopsy
To investigate in a prospective, observational study whether transperineal prostate biopsy (TPbx) results in patient‐reported quality‐of‐life (QoL) changes from baseline in the first 3‐months afterExpand
Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management
Simple Summary This review is a summary of recent findings on the role of prostate-specific membrane antigen (PSMA) in metastatic castration-resistant prostate cancer (mCRPC) and how they can beExpand
The Diagnosis and Treatment of Prostate Cancer: A Review
TLDR
Advances in the diagnosis and treatment of prostate cancer have improved the ability to stratify patients by risk and allowed clinicians to recommend therapy based on cancer prognosis and patient preference. Expand
Outcomes Following Various Treatment Options for Clinically Localized Prostate Cancer
TLDR
This review aimed to summarize recent literatures on surgery, radiotherapy, and expectant management, which have been the mainstays of treatment for localized prostate cancer; and introduce several treatments for the concept of focal therapy. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 218 REFERENCES
Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer
Study Type – Therapy (outcomes)
Early prostate cancer – which treatment do men prefer and why?
TLDR
Study Type – Preference (prospective cohort)’s level of evidence’1b; andLevel of Evidence (level of evidence) 1b. Expand
Surgical management after active surveillance for low‐risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment
Study Type – Therapy (case control)
Level of Evidence 3b
Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience
TLDR
To examine the outcome of patients diagnosed with ‘low‐risk’ prostate cancer managed by active surveillance (AS), a large number of patients were found to be at low risk of developing prostate cancer. Expand
Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management
TLDR
The authors sought to define the outcomes of three common strategies for managing patients with nonmetastatic prostate carcinoma: expectant management, radiotherapy, and radical prostatectomy. Expand
Prostate‐specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer
TLDR
Study Type – Prognosis (retrospective cohort analysis) – Results show clear trends in prognosis for long-term survival and disease progression in patients diagnosed with central giant cell granuloma. Expand
High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound‐guided template saturation biopsy
TLDR
Study Type – Diagnostic (exploratory cohort) and follow-up studies to explore the role of EMT in the development of central nervous system disease and its role in Parkinson's disease. Expand
Prostate cancer active surveillance and health‐related quality of life: results of the Finnish arm of the prospective trial
Study Type – Therapy (case series)
Active surveillance for prostate cancer: an Australian experience
TLDR
A large cohort of Australian men who chose active surveillance as initial management of their low‐risk prostate cancer opted for active surveillance, and the patient and cancer characteristics as well as outcomes were assessed. Expand
Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study
Study Type – Therapy (prospective cohort)
Level of Evidence 2b
...
1
2
3
4
5
...